HERG Technology

In addition to the Oncology pipeline, Sentinel has developed a proprietary technique which enables the development of safer small molecule therapeutics through abolishment of the hERG potassium channel activity inherent in many small molecule lead discovery programmes. This technology is available for non-exclusive licensing.